Literature DB >> 3877717

The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.

R A Wall, D C Mabey, C S Bello, D Felmingham.   

Abstract

We have compared the in-vitro activity of 12 quinolone antibiotics against 50 recent isolates of Haemophilus ducreyi from The Gambia. While these isolates were relatively resistant to the parent compounds, the newly synthesized quinolones exerted significant activity against H. ducreyi. Ciprofloxacin and ofloxacin were the most active compounds (MIC90 0.03 mg/l).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877717     DOI: 10.1093/jac/16.2.165

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Treating chancroid: summary of studies in southern Africa.

Authors:  R C Ballard; M O Duncan; H G Fehler; Y Dangor; F L Exposto; A S Latif
Journal:  Genitourin Med       Date:  1989-01

Review 3.  Quinolone antibacterial agents for the treatment of genitourinary tract infections.

Authors:  T J Babinchak; R J Fass
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

4.  Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.

Authors:  Y Dangor; S D Miller; F da L Exposto; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M C Thebault; G Arlet; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

6.  [Results of treatment of bacterial inflammation of the skin with enoxacin].

Authors:  H Mensing
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 7.  [Enoxacin: spectrum and activity of its antibacterial effect].

Authors:  A Bauernfeind; H Flamm; H Grimm; H Hahn; F Kayser; W Opferkuch; J Potel; R Malottke; H G Sonntag; W H Traub
Journal:  Infection       Date:  1986       Impact factor: 3.553

8.  Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients.

Authors:  A Traisupa; C Wongba; P Tesavibul
Journal:  Infection       Date:  1988       Impact factor: 3.553

9.  Asymptomatic carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction.

Authors:  S Hawkes; B West; S Wilson; H Whittle; D Mabey
Journal:  Genitourin Med       Date:  1995-08

Review 10.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.